Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 57Pancreatic Neoplasms 39Carcinoma, Non-Small-Cell Lung 29Triple Negative Breast Neoplasms 20Neoplasms 17Neoplasm Metastasis 11Lung Neoplasms 10Squamous Cell Carcinoma of Head and Neck 9Ovarian Neoplasms 8Melanoma 7Head and Neck Neoplasms 6Breast Neoplasms, Male 6Adenocarcinoma 6Urinary Bladder Neoplasms 5Inflammatory Breast Neoplasms 5Carcinoma 5Sarcoma 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Pancreatic Diseases 4Fallopian Tube Neoplasms 4Cholangiocarcinoma 4Carcinoma, Ovarian Epithelial 4Stomach Neoplasms 3Small Cell Lung Carcinoma 3Pancreatic Adenocarcinoma 3Esophageal Neoplasms 3Endocrine System Diseases 3Endocrine Gland Neoplasms 3Digestive System Neoplasms 3Digestive System Diseases 3

Interventions

paricalcitol 1Taxes 1Gemcitabine 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Resectable Pancreatic Cancer × Albumin-Bound Paclitaxel × Clear all
NCT03138720 2026-04-22

Pre-operative Treatment for Patients With Untreated Pancreatic Cancer

HonorHealth Research Institute

Phase 2 Completed
40 enrolled 22 charts
Gastrointestinal

Resectable Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡